Home LiteratureArticle Details
PMID: 6403470 Published · ppublish English Journal Article

Preparation and physicochemical and immunological characterization of polysaccharide-outer membrane protein complexes of Neisseria meningitidis.

Infection and immunity ·Vol. 40 ·No. 1 ·1983-04-00 ·Pages 369-80

Beuvery EC, Miedema F, van Delft RW, Haverkamp J, Leussink AB, te Pas BJ, Teppema KS, Tiesjema RH

Abstract

A crude complex containing group C polysaccharide, outer membrane proteins, and lipopolysaccharide (LPS) was isolated from the cell-free culture liquid of Neisseria meningitidis serogroup C, serotype 2a. Group C polysaccharide and LPS were removed from this complex, resulting in an outer membrane complex and a purified complex, respectively. Analysis by electron microscopy showed the outer membrane origin of the crude complex and the outer membrane complex, whereas such a structure was absent in the purified complex. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis patterns of the three complexes were identical. Pyrolysis-mass spectrometry data correlated well with those obtained by the biochemical assays and suggested a low LPS content in the purified complex and a low polysaccharide content in the outer membrane complex. The purified complex was shown to be nonpyrogenic and could be prepared with the same yield as that of purified polysaccharide. The immunogenic activities of the complexes were studied in mice. The antibodies were measured by the enzyme-linked immunosorbent assay; and the bactericidal antibody assay. All complexes induced immunoglobulin G antibodies to group C polysaccharide as well as to the serotype antigen, although the removal of polysaccharide and LPS resulted in a reduction of the immunogenic activities of outer membrane complex and purified complex, respectively. A second dose of all complexes produced a clear booster effect of both antibody responses. The antibodies were bactericidal.

MeSH Terms
Animals Antibodies, Bacterial/analysis,biosynthesis Bacterial Outer Membrane Proteins Bacterial Vaccines/analysis,immunology Chemical Phenomena Chemistry, Physical Enzyme-Linked Immunosorbent Assay Female Immunization, Secondary Limulus Test Lipopolysaccharides/immunology,isolation & purification Male Membrane Proteins/immunology,isolation & purification Meningitis, Meningococcal/immunology Mice Neisseria meningitidis/immunology,ultrastructure Polysaccharides, Bacterial/immunology,isolation & purification Rabbits
Chemicals
Antibodies, Bacterial Bacterial Outer Membrane Proteins Bacterial Vaccines Lipopolysaccharides Membrane Proteins Polysaccharides, Bacterial
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Beuvery E C
Miedema F
van Delft R W
Haverkamp J
Leussink A B
te Pas B J
Teppema K S
Tiesjema R H
References (28)
28 references, click to expand
  1. Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model.
    J Exp Med. 1978 Mar 1;147(3):629-44 PMID: 416164
  2. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age.
    N Engl J Med. 1977 Sep 29;297(13):686-91 PMID: 408682
  3. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  4. Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man.
    J Clin Invest. 1979 May;63(5):836-48 PMID: 109466
  5. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.
    Pediatrics. 1977 Nov;60(5):730-7 PMID: 335348
  6. Human immunity to the meningococcus. I. The role of humoral antibodies.
    J Exp Med. 1969 Jun 1;129(6):1307-26 PMID: 4977280
  7. Characterization of Neisseria meningitidis capsular polysaccharides containing sialic acid by pyrolysis mass spectrometry.
    Anal Biochem. 1980 May 15;104(2):407-18 PMID: 6778246
  8. Quantitative and qualitative studies on the primary antibody response to pneumococcal polysaccharides at ehe cellular level.
    J Immunol. 1969 Dec;103(6):1342-8 PMID: 4391281
  9. Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method.
    Biochim Biophys Acta. 1957 Jun;24(3):604-11 PMID: 13436486
  10. Safety and immunogenicity of a Neisseria meningitidis type 2 protein vaccine in animals and humans.
    J Infect Dis. 1978 Jun;137(6):728-39 PMID: 77885
  11. Human antibody response to three meningococcal outer membrane antigens: comparison by specific hemagglutination assays.
    Infect Immun. 1974 Nov;10(5):975-84 PMID: 16558113
  12. Immunoglobulin M and G antibody responses and persistence of these antibodies in adults after vaccination with a combined meningococcal group A and group C polysaccharide vaccine.
    Infect Immun. 1982 Aug;37(2):579-85 PMID: 6811434
  13. Comparison of the induction of immunoglobulin M and G antibodies in mice with purified pneumococcal type 3 and meningococcal group C polysaccharides and their protein conjugates.
    Infect Immun. 1982 Jul;37(1):15-22 PMID: 6809623
  14. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.
    J Biol Chem. 1969 Aug 25;244(16):4406-12 PMID: 5806584
  15. Immunochemical characterization of Neisseria meningitidis serotype antigens by immunodiffusion and SDS-polyacrylamide gel electrophoresis immunoperoxidase techniques and the distribution of serotypes among cases and carriers.
    J Gen Microbiol. 1980 Feb;116(2):465-73 PMID: 6768838
  16. An outer membrane protein of Neisseria meningitidis group B responsible for serotype specificity.
    J Exp Med. 1974 Jul 1;140(1):87-104 PMID: 4134571
  17. Immunisation against bacterial meningitis.
    J Infect. 1981 Mar;3(1 Suppl):71-9 PMID: 7185955
  18. Growth Requirements of the Meningococcus.
    J Bacteriol. 1942 Jun;43(6):757-61 PMID: 16560537
  19. Human immunity to the meningococcus. II. Development of natural immunity.
    J Exp Med. 1969 Jun 1;129(6):1327-48 PMID: 4977281
  20. Role of protein serotype antigens in protection against disease due to Neisseria meningitidis.
    J Infect Dis. 1977 Aug;136 Suppl:S84-90 PMID: 408436
  21. Prospects for the prevention of bacterial meningitis with polysaccharide vaccines.
    Bull World Health Organ. 1978;56(4):509-18 PMID: 31985
  22. Isolation and characterization of a native cell wall complex from Neisseria meningitidis.
    Infect Immun. 1972 Nov;6(5):835-51 PMID: 4629210
  23. Protection against group B meningococcal disease: evaluation of serotype 2 protein vaccines in a mouse bacteremia model.
    Infect Immun. 1979 Oct;26(1):110-7 PMID: 115794
  24. Five structural classes of major outer membrane proteins in Neisseria meningitidis.
    J Bacteriol. 1981 Apr;146(1):69-78 PMID: 6783622
  25. Loss of endotoxin liberation in Neisseria meningitidis.
    Acta Pathol Microbiol Scand B. 1981 Aug;89(4):271-8 PMID: 6797242
  26. Protein measurement with the Folin phenol reagent.
    J Biol Chem. 1951 Nov;193(1):265-75 PMID: 14907713
  27. Release of endotoxin in the form of cell wall blebs during in vitro growth of Neisseria meningitidis.
    J Exp Med. 1973 Nov 1;138(5):1156-67 PMID: 4200775
  28. The limulus amebocyte lysate test micromethod and application in the control of sera and vaccines.
    Dev Biol Stand. 1977;34:15-20 PMID: 838139
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1983-04-00
Pages
369-80
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC264857
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com